SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-160495
Filing Date
2021-05-13
Accepted
2021-05-13 16:11:35
Documents
67
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d162770d10q.htm 10-Q 899627
2 EX-10.1 d162770dex101.htm EX-10.1 25451
3 EX-31.1 d162770dex311.htm EX-31.1 7223
4 EX-31.2 d162770dex312.htm EX-31.2 7196
5 EX-32.1 d162770dex321.htm EX-32.1 5854
  Complete submission text file 0001193125-21-160495.txt   4753940

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ymtx-20210331.xml EX-101.INS 813997
7 XBRL TAXONOMY EXTENSION SCHEMA ymtx-20210331.xsd EX-101.SCH 48396
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ymtx-20210331_cal.xml EX-101.CAL 50185
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ymtx-20210331_def.xml EX-101.DEF 221336
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ymtx-20210331_lab.xml EX-101.LAB 439343
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ymtx-20210331_pre.xml EX-101.PRE 333453
Mailing Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135
Business Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135 617-409-5300
YUMANITY THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37695 | Film No.: 21919741
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences